tiprankstipranks
Inhibrx Biosciences Inc (INBX)
NASDAQ:INBX
US Market

Inhibrx Biosciences Inc (INBX) Income Statement

Compare
17 Followers

Inhibrx Biosciences Inc Income Statement

Last quarter (Q3 2024), Inhibrx Biosciences Inc's total revenue was $0.00, a decrease of -100.00% from the same quarter last year. In Q3, Inhibrx Biosciences Inc's net income was $-43.86M. See Inhibrx Biosciences Inc’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 1.80M$ 2.18M$ 7.13M$ 12.81M$ 9.09M
Gross Profit
$ 609.00K$ -668.00K$ 4.44M$ -60.69M$ -38.81M
Operating Expenses
$ 219.83M$ 131.29M$ 83.69M$ 80.25M$ 52.81M
Depreciation and Amortization
$ 1.19M$ 1.23M$ 2.69M$ 2.39M$ 2.52M
EBITDA
$ -206.69M$ -125.82M$ -76.56M$ -67.44M$ -42.60M
Operating Income
$ -219.22M$ -129.12M$ -76.56M$ -67.44M$ -43.71M
Other Income/Expenses
$ -20.50M$ -29.90M$ -5.20M$ -8.19M$ -6.79M
Pretax Income
$ -239.72M$ -145.22M$ -81.77M$ -75.63M$ -50.50M
Net Income
$ -241.36M$ -145.23M$ -81.77M$ -75.64M$ -51.40M
Per Share Metrics
$ ―$ ―$ ―$ ―$ ―
Basic EPS
$ -5.12$ -3.62$ -2.15$ -2.99$ -1.41
Diluted EPS
$ -5.12$ -3.62$ -2.15$ -2.99$ -1.41
Weighted Average Shares Outstanding
47.13M 40.11M 38.01M 25.26M 36.55M
Weighted Average Shares Outstanding (Diluted)
47.13M 40.11M 38.01M 25.26M 36.55M
Currency in USD

Inhibrx Biosciences Inc Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis